What the literature shows about HCW mental health

The numbers on healthcare worker mental health are not subtle. Reports compiled by Dyrbye and colleagues for the National Academy of Medicine, drawing on Mayo Clinic Proceedings data published in 2017, found that more than half of U.S. physicians report at least one symptom of burnout, with rates of depression and suicidal ideation elevated relative to the general population. The pandemic widened those gaps. Postgraduate trainees, emergency physicians, and ICU clinicians showed especially sharp increases.

Nurses sit in a similar place. A 2020 paper by Davidson and colleagues in Worldviews on Evidence-Based Nursing documented that nurses experience suicide rates higher than the general population, with depression and PTSD common in the years surrounding the pandemic. Surveys of CRNAs, respiratory therapists, paramedics, and hospital chaplains show variations on the same pattern. The exposure is moral injury, sleep deprivation, exposure to repeated trauma, and a workplace culture that has historically rewarded silence.

Healthcare workers are also less likely than the general population to seek care. The American Medical Association and the American Nurses Association have both flagged this gap publicly. The reasons are practical and cultural: long shifts, no time, fear of being seen as impaired, fear of credentialing questions, and a deep professional habit of treating one's own symptoms as a problem to be managed quietly.

Why HCWs underutilize care, and what gets in the way

If you have spent any time in a hospital break room you have heard versions of the same conversation. Someone is exhausted, someone is grieving a patient, someone is white-knuckling through a divorce or a child's diagnosis. Then a code is called and everyone goes back to work. The internal voice says: I should be able to handle this. Other people have it worse. If I take time, my colleagues cover.

That voice is not a personal flaw. It is a professional norm, reinforced for decades. The cost is that small problems become bigger ones, and bigger ones become the kind of crisis that ends careers and lives. Several specific barriers come up over and over again in our consultations with healthcare workers:

Ketamine does not solve all of those barriers. It does, however, fit a particular profile of patient: someone with a clear depression or trauma diagnosis who has already tried first-line treatment, who has limited time, and who needs an option that does not require months of ramp-up.

The MDD and PTSD evidence that applies

There are no large randomized controlled trials of ketamine specifically in healthcare workers. There is, however, a solid body of evidence in the underlying conditions HCWs disproportionately carry: major depressive disorder, treatment-resistant depression, and PTSD. That is the evidence that applies.

For depression, the foundational study is Murrough et al., published in 2013 in the American Journal of Psychiatry. In a randomized controlled trial of 73 patients with treatment-resistant depression, a single IV ketamine infusion produced a 64% response rate at 24 hours, compared with 28% for midazolam, an active control. Subsequent work has replicated the speed and magnitude of the effect across multiple academic centers, with response often appearing within hours rather than weeks. Spravato (esketamine) was later approved by the FDA for treatment-resistant depression and for major depressive disorder with acute suicidal ideation.

For PTSD, the most important randomized data come from Feder and colleagues in the American Journal of Psychiatry in 2021. Their trial randomized patients with chronic PTSD to six ketamine infusions or six midazolam infusions over two weeks. The ketamine arm showed significantly greater reduction in PTSD symptom severity, with effects that held up across follow-up assessments. Earlier work by the same group had shown a similar signal with a single infusion. The pattern is consistent: repeated dosing produces broader and more durable effects than a single session.

Ketamine is FDA-approved as an anesthetic. Its use for depression, PTSD, and other psychiatric conditions outside of Spravato is off-label, prescribed by clinicians under the same framework that governs much of psychiatric medicine. Research suggests it is one of the more rapidly acting interventions available for these conditions, but it is not a cure and not everyone responds. Hedging is appropriate.

Confidentiality and licensure: what we will and will not disclose

Healthcare workers ask us about confidentiality before they ask us about almost anything else. Here is the honest version.

Routine outpatient mental health treatment is covered by HIPAA. We do not contact your employer, your hospital, your group practice, or your licensing board to report that you are receiving care. We do not respond to informal inquiries from coworkers. Records are released only with your written authorization, with the standard legal exceptions (court order, mandatory reporting of imminent harm, and similar narrow categories).

Tennessee licensing boards generally focus on impairment in the workplace and on diversion, not on whether a clinician has ever sought treatment. Many board applications now use language designed to encourage care-seeking rather than punish it, asking about current impairment rather than lifetime history. We are not your attorney, so for specific licensure questions we encourage you to talk to your professional association or counsel. What we can tell you is that the most common path through this is the boring one: you get treated, you keep working, no one outside your circle of consent ever knows.

Marla Peterson, CRNA, is herself a healthcare worker. She oversees every infusion at our clinic. That is relevant to safety and monitoring, which is covered in our broader safety overview. It is also relevant in another way: HCW patients tend to feel less performative when the clinician in the room understands their world without being briefed. You can ask the questions you actually want to ask. You can read more about the CRNA role if you are curious about what that level of monitoring involves.

What a session looks like for a working clinician

A typical induction series is six infusions over two to three weeks. Each session takes about two hours from check-in to discharge. You arrive, change into something comfortable, and we place an IV. The infusion itself runs over roughly 40 to 50 minutes. During that time you are in a private, low-light room with vitals continuously monitored. Most patients describe the experience as a quiet, dissociative drift. Some report visual or emotional content; others mostly feel a soft separation from their day.

After the infusion, we give you time to come back to baseline before discharge. You will need a driver. Most patients are clear-headed by the next morning. For non-clinical work the next day, that is usually fine. For complex clinical shifts, especially those involving surgery or controlled-substance handling, we recommend planning a buffer and discussing timing with us during your consultation.

Side effects during the infusion are common and usually mild: transient elevations in blood pressure and heart rate, mild nausea, dissociation, and occasional dizziness. Significant adverse events are uncommon but possible, which is why anesthesia-level monitoring matters. Studies indicate the safety profile in carefully selected outpatients is well characterized, but no medication is risk-free.

Scheduling, recovery time, and getting back to work

Most healthcare workers we see schedule sessions in one of three ways: late afternoons after a clinic day, on regular days off, or stacked on a short stretch of PTO. Shift workers tend to use post-call days. Surgical teams tend to use Fridays or non-OR days. There is no one right pattern; the goal is to give yourself a real recovery buffer rather than driving back to a 6 a.m. case.

Cost is a piece of this conversation we cannot avoid. IV ketamine for psychiatric or pain conditions is off-label and is generally not covered by insurance. At Music City Ketamine, sessions are $475 each. We do not bundle, upsell, or pressure anyone into a longer course than the evidence supports. A typical induction series runs six sessions; many patients then space out to maintenance every four to eight weeks based on response. Some HCWs use FSA or HSA funds where their plan allows.

If you are also dealing with overlapping burnout, trauma exposure, or sleep collapse, we will talk through how those interact with treatment. We are not going to oversell the protocol. Some people respond robustly, some respond partially, and some do not respond. We will tell you honestly which group you appear to be in as we go.

When peer programs and ketamine work together

Most of the strongest signals we see in HCW patients come from people who pair ketamine with something else: a therapist they trust, a peer support program through their hospital or specialty society, an honest weekly check-in with a friend who also works in medicine. Ketamine seems to open a window. What happens in that window is shaped by the rest of someone's life.

Peer support programs deserve specific mention. The Foundation for Physician Wellness, the American Association of Nurse Anesthesiology peer assistance network, the AMA's Joy in Medicine work, and various specialty-specific programs offer confidential support that complements medical treatment. None of those programs can replicate what ketamine does pharmacologically. None of what ketamine does pharmacologically replicates what peer support does relationally. The two are different tools.

For HCWs who carry traumatic exposure that meets criteria for PTSD, we encourage continued work with a trauma-informed therapist, ideally one who has experience working with first responders and clinicians. The same goes for HCWs whose primary issue is treatment-resistant depression: continuity with a prescriber matters, and we coordinate with your existing team rather than asking you to abandon them. For more on adjacent populations, our pieces on first responders, veterans, and ketamine for PTSD may be useful.

Never start, stop, or change a psychiatric medication on your own; talk to your prescribing provider. If you are in crisis, call or text 988. The point of writing all this down is not to push anyone toward treatment. The point is to make it easier for healthcare workers to consider an option they have probably been talking about with patients for years without giving themselves permission to consider it personally.